期刊文献+

糖原累积症患儿的临床特点分析 被引量:2

Clinical analysis of glycogen storage disease
原文传递
导出
摘要 目的总结糖原累积症的临床特点,提高临床医师对该病的认识,减少误诊、误治。方法回顾在本院治疗的6例糖原累积症患儿的临床资料并结合相关文献进行分析。结果糖原累积症主要的首发症状为肝脏增大或体检发现肝功能异常,其他常见的临床表现为腹部膨隆、生长发育迟缓、鼻衄、反复呼吸道感染、低血糖、代谢性酸中毒等。所有患儿经口服生的玉米淀粉治疗,症状均明显好转。结论发现患儿肝肿大及肝功能异常,要警惕糖原累积症,临床确诊后要及早口服生玉米淀粉并坚持长期治疗。 Objective: To summary the clinic characteristic of glycogen storage disease elevate recognition and to decrease misdiagnosed and mistreatment of the glycogen storage disease. Methods : To review the clinical history of six cases glycogen storage disease and to analyze clinical characteristic of glycogen storage disease combining with pertinent literature. Results : The first clinical manifestation of glycogen storage disease was hepatomegaly or disfunction of liver found in health examination and the other frequent clinical manifestation were abdominal bulge, abdominal bulge, epistaxis, epistaxis, respiratory infection, glyeopenia, metabolic acidosis, et al. All children were better after taking crude amylum maydis orally. Conclusions: Glycogen storage diseas must be concluded if the child was hepatomegaly or disfunction of liver. All the children with glycogen storage disease must take crude amylum maydis orally and insist on long term therapy.
作者 刘强 郑敏
出处 《中国优生与遗传杂志》 2013年第9期122-123,共2页 Chinese Journal of Birth Health & Heredity
关键词 糖原累积症 诊断 治疗 Glycogen storage disease Diagnose Treatment
  • 相关文献

参考文献13

  • 1Shieh JJ, Lu YH, Huang SW, et al. Misdiagnosis as steatohepatitis in a family with mild glycogen storage disease type 1 a [ J ]. Gene, 2012,509( 1 ) : 154 - 157.
  • 2Wang DQ, Fiske LM, Carreras CT, et al. Natural history of hepato- cellular adenoma formation in glycogen storage disease type I [ J ]. J Pediatr, 2011, 159(3): 442 -446.
  • 3Zaidman CM, Malkus EC, Siener C, et al. Qualitative and quantita- tive skeletal muscle ultrasound in late - onset acid maltase deficiency [J]. Muscle Nerve, 2011, 44(3): 418 -4.23.
  • 4Davis MK, Valentine JF, Weinstein DA, et al. Antibodies to CBirl are associated with glycogen storage disease type Ib [ J ]. J Pediatr Gastroenterol Nutr, 2010 Ju1,51 ( 1 ) : 14 - 18.
  • 5Valayannopoulos V, Bajolle F, Arnoux JB, et al. Successful treat- ment of severe eardiomyopathy in glycogen storage disease type III With D, L - 3 - hydroxybutyrate, ketogenic and high - protein diet [J]. Pediatr Res, 2011,70(6):638 -641.
  • 6Grelorst A, Schreurs M, Oosterveer MH, et al. Carbohydrate re- sponse- element binding protein(ChREBP) and not the liver X re- ceptor ct(LXRct) mediates elevated hepatic lipogenic gene expression in a mouse model of glycogen storage disease type 1 [J]. Bioehem J, 2010,432 (2) : 249 - 254.
  • 7Weinstein DA, Correia CE, Saunders AC, et al. Hepatic glycogen syn- thase deficiency:an infrequently recognized cause of ketotic hypogly- cemia[J]. Mol Genet Metab, 2006, 87(4):284 - 288.
  • 8Muraoka T, Murao K, Imacbi H, et al. Novel mutations in the gene encoding acid ct - 1,4 - glucosidase in a patient with late - onset gly- cogen storage disease type II (Pompe disease ) with impaired intelli- gence[J]. Intern Ied, 2011,50(2A):2987-2991.
  • 9Araoka T, Takeoka H, Abe H, et al. Early diagnosis and treatment may prevent the development of complications in an adult patient with glycogen storage disease type Ia[J]. Intern Med, 2010, 49( 16):1787 - 1792.
  • 10Yiu WH, Mead PA, Jun HS, et al. Oxidative stress mediates ne- phrepathy in type Ia glycogen storage disease [ J ]. Lab Invest,2010, 90(4):620 -629.

同被引文献14

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部